MedPath

PLERIXAFOR GLENMARK 20 MG/ML SOLUCION INYECTABLE EFG

PLERIXAFOR GLENMARK 20 MG/ML SOLUCION INYECTABLE EFG

Commercialized
Register Number

88904

Prescription Type

Uso Hospitalario

Authorization Date

Jun 14, 2023

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number88904
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

PLERIXAFORActive
Quantity: 20 mg
Name: PLERIXAFOR

ATC CLASSIFICATION (3)

L03A
L03AX
L03AX16

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.